Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

NCT00967031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Cancer

Interventions

DRUG: capecitabine
DRUG: lapatinib ditosylate
OTHER: circulating tumor cell analysis
OTHER: laboratory biomarker analysis

Sponsor

UNICANCER